Antitumor natural products targeting PPAR-gamma and their combination effect with clinically used anticancer agents
Project/Area Number |
25460134
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Natural medicines
|
Research Institution | Tokyo University of Pharmacy and Life Science |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
松尾 侑希子 東京薬科大学, 薬学部, 助教 (70434016)
|
Project Period (FY) |
2013-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | PPAR-gamma / Santalum album / セスキテルペン / 選択的腫瘍細胞毒性 / カンゾウ / プレニルイソフラボノイド誘導体 / ビャクシ / 新規クマリン誘導体 / PPAR-γリガンド活性 / 天然物 / 腫瘍細胞毒性 / 併用効果 / マオウ / ハマボウフウ / フラノクマリン / 培養腫瘍細胞 / HL-60細胞 / A549細胞 |
Outline of Final Research Achievements |
Magnolol, a natural PPAR-gamma agonist, enhanced the tumor selective cytotoxic activity of a new sesquiterpene from Santalum album heart wood against HL-60 leukemia cells by more than 100 times. Furthermore, a prenylisoflavonoid derivative from Glycyrrhiza glabra roots and a new coumarin derivative from Angelica dahurica roots exhibited PPAR-gamma agonist activity and attenuated the cytotoxicity of etoposide, a clinically used anticancer agent, against A549 lung adenocarcinoma cells. The kampo prescription of Shimpito Extract and Ephedra Herb extract showed PPAR-gamma agonist activity. Three prenylfuranocoumarin derivatives were isolated from Glehnia littoralis roots and rhizomes as the PPAR-gamma agonists.
|
Report
(5 results)
Research Products
(10 results)